The Effect of Short-Term Hyperglycemia on the Innate Immune System
While many of the supply chain issues with accessing GLP-1s have been eased, there are still large barriers for most consumers interested in taking these drugs
2013;27(3):303-313 Elam MB, Hunninghake DB, Davis KB, et al
Large randomized clinical trials have demonstrated average weight reductions of approximately 15% of body weight when combined with lifestyle modification, making Wegovy one of the most effective obesity medications currently available
doi: 10.1016/j.bbadis.2023.166742 132 FairlieWDTranSLeeEF
Market and Regulatory Pressure: Where the System Is Moving The rapid expansion of GLP-1 therapies has placed them at the center of market competition, regulatory scrutiny, and policy debate